nodes	percent_of_prediction	percent_of_DWPC	metapath
Nadolol—ABCB1—Dactinomycin—testicular cancer	0.144	0.284	CbGbCtD
Nadolol—ABCB1—Vinblastine—testicular cancer	0.0901	0.178	CbGbCtD
Nadolol—ABCB1—Cisplatin—testicular cancer	0.0826	0.163	CbGbCtD
Nadolol—ABCB1—Etoposide—testicular cancer	0.0811	0.16	CbGbCtD
Nadolol—ABCB1—Doxorubicin—testicular cancer	0.0553	0.109	CbGbCtD
Nadolol—ABCB1—Methotrexate—testicular cancer	0.0536	0.106	CbGbCtD
Nadolol—Ventricular extrasystoles—Doxorubicin—testicular cancer	0.00199	0.00403	CcSEcCtD
Nadolol—Cough—Bleomycin—testicular cancer	0.00196	0.00397	CcSEcCtD
Nadolol—Paraesthesia—Vinblastine—testicular cancer	0.00195	0.00395	CcSEcCtD
Nadolol—Alopecia—Ifosfamide—testicular cancer	0.00195	0.00395	CcSEcCtD
Nadolol—Bradycardia—Cisplatin—testicular cancer	0.00193	0.00392	CcSEcCtD
Nadolol—Chest pain—Bleomycin—testicular cancer	0.00191	0.00387	CcSEcCtD
Nadolol—Dysarthria—Doxorubicin—testicular cancer	0.0019	0.00385	CcSEcCtD
Nadolol—Decreased appetite—Vinblastine—testicular cancer	0.00189	0.00382	CcSEcCtD
Nadolol—Body temperature increased—Chlorambucil—testicular cancer	0.00187	0.00379	CcSEcCtD
Nadolol—Pain—Vinblastine—testicular cancer	0.00185	0.00376	CcSEcCtD
Nadolol—Constipation—Vinblastine—testicular cancer	0.00185	0.00376	CcSEcCtD
Nadolol—Atrioventricular block—Doxorubicin—testicular cancer	0.00185	0.00376	CcSEcCtD
Nadolol—Pulmonary oedema—Methotrexate—testicular cancer	0.00185	0.00374	CcSEcCtD
Nadolol—Fluid retention—Epirubicin—testicular cancer	0.00184	0.00374	CcSEcCtD
Nadolol—Oedema—Bleomycin—testicular cancer	0.00183	0.00371	CcSEcCtD
Nadolol—Visual impairment—Cisplatin—testicular cancer	0.00183	0.00371	CcSEcCtD
Nadolol—Agranulocytosis—Etoposide—testicular cancer	0.00181	0.00367	CcSEcCtD
Nadolol—Vision blurred—Ifosfamide—testicular cancer	0.00181	0.00366	CcSEcCtD
Nadolol—Dry eye—Epirubicin—testicular cancer	0.00179	0.00364	CcSEcCtD
Nadolol—Tinnitus—Cisplatin—testicular cancer	0.00177	0.00359	CcSEcCtD
Nadolol—Anorexia—Bleomycin—testicular cancer	0.00175	0.00354	CcSEcCtD
Nadolol—Pulmonary oedema—Epirubicin—testicular cancer	0.00173	0.0035	CcSEcCtD
Nadolol—Hypotension—Bleomycin—testicular cancer	0.00171	0.00347	CcSEcCtD
Nadolol—Oedema—Dactinomycin—testicular cancer	0.00171	0.00346	CcSEcCtD
Nadolol—Fluid retention—Doxorubicin—testicular cancer	0.00171	0.00346	CcSEcCtD
Nadolol—Asthenia—Chlorambucil—testicular cancer	0.0017	0.00344	CcSEcCtD
Nadolol—Alopecia—Cisplatin—testicular cancer	0.00168	0.0034	CcSEcCtD
Nadolol—Pruritus—Chlorambucil—testicular cancer	0.00167	0.00339	CcSEcCtD
Nadolol—Cough—Ifosfamide—testicular cancer	0.00167	0.00339	CcSEcCtD
Nadolol—Dry eye—Doxorubicin—testicular cancer	0.00166	0.00336	CcSEcCtD
Nadolol—Hypertension—Ifosfamide—testicular cancer	0.00166	0.00336	CcSEcCtD
Nadolol—Paraesthesia—Bleomycin—testicular cancer	0.00164	0.00333	CcSEcCtD
Nadolol—Dyspnoea—Bleomycin—testicular cancer	0.00163	0.00331	CcSEcCtD
Nadolol—Chest pain—Ifosfamide—testicular cancer	0.00163	0.00331	CcSEcCtD
Nadolol—Flatulence—Cisplatin—testicular cancer	0.00163	0.0033	CcSEcCtD
Nadolol—Anorexia—Dactinomycin—testicular cancer	0.00163	0.0033	CcSEcCtD
Nadolol—Diarrhoea—Chlorambucil—testicular cancer	0.00162	0.00328	CcSEcCtD
Nadolol—Pulmonary oedema—Doxorubicin—testicular cancer	0.0016	0.00324	CcSEcCtD
Nadolol—Decreased appetite—Bleomycin—testicular cancer	0.00159	0.00323	CcSEcCtD
Nadolol—Visual disturbance—Methotrexate—testicular cancer	0.00159	0.00322	CcSEcCtD
Nadolol—Pain—Bleomycin—testicular cancer	0.00157	0.00317	CcSEcCtD
Nadolol—Oedema—Ifosfamide—testicular cancer	0.00157	0.00317	CcSEcCtD
Nadolol—Vision blurred—Cisplatin—testicular cancer	0.00156	0.00316	CcSEcCtD
Nadolol—Asthenia—Vinblastine—testicular cancer	0.00156	0.00315	CcSEcCtD
Nadolol—Cardiac failure congestive—Epirubicin—testicular cancer	0.00155	0.00315	CcSEcCtD
Nadolol—Alopecia—Etoposide—testicular cancer	0.00154	0.00312	CcSEcCtD
Nadolol—Lethargy—Methotrexate—testicular cancer	0.00154	0.00312	CcSEcCtD
Nadolol—Hyperhidrosis—Ifosfamide—testicular cancer	0.00151	0.00307	CcSEcCtD
Nadolol—Vomiting—Chlorambucil—testicular cancer	0.0015	0.00305	CcSEcCtD
Nadolol—Anorexia—Ifosfamide—testicular cancer	0.00149	0.00302	CcSEcCtD
Nadolol—Decreased appetite—Dactinomycin—testicular cancer	0.00149	0.00301	CcSEcCtD
Nadolol—Diarrhoea—Vinblastine—testicular cancer	0.00148	0.00301	CcSEcCtD
Nadolol—Fatigue—Dactinomycin—testicular cancer	0.00147	0.00298	CcSEcCtD
Nadolol—Hypotension—Ifosfamide—testicular cancer	0.00146	0.00296	CcSEcCtD
Nadolol—Pain—Dactinomycin—testicular cancer	0.00146	0.00296	CcSEcCtD
Nadolol—Body temperature increased—Bleomycin—testicular cancer	0.00145	0.00293	CcSEcCtD
Nadolol—Cardiac failure—Epirubicin—testicular cancer	0.00144	0.00293	CcSEcCtD
Nadolol—Lethargy—Epirubicin—testicular cancer	0.00144	0.00292	CcSEcCtD
Nadolol—Cardiac failure congestive—Doxorubicin—testicular cancer	0.00144	0.00292	CcSEcCtD
Nadolol—Irritability—Methotrexate—testicular cancer	0.00144	0.00291	CcSEcCtD
Nadolol—Dizziness—Vinblastine—testicular cancer	0.00143	0.00291	CcSEcCtD
Nadolol—Mood swings—Methotrexate—testicular cancer	0.00143	0.00289	CcSEcCtD
Nadolol—Diplopia—Epirubicin—testicular cancer	0.00141	0.00286	CcSEcCtD
Nadolol—Nausea—Chlorambucil—testicular cancer	0.00141	0.00285	CcSEcCtD
Nadolol—Paraesthesia—Ifosfamide—testicular cancer	0.00141	0.00285	CcSEcCtD
Nadolol—Dyspnoea—Ifosfamide—testicular cancer	0.0014	0.00283	CcSEcCtD
Nadolol—Affect lability—Epirubicin—testicular cancer	0.00139	0.00281	CcSEcCtD
Nadolol—Vomiting—Vinblastine—testicular cancer	0.00138	0.00279	CcSEcCtD
Nadolol—Decreased appetite—Ifosfamide—testicular cancer	0.00136	0.00276	CcSEcCtD
Nadolol—Body temperature increased—Dactinomycin—testicular cancer	0.00135	0.00274	CcSEcCtD
Nadolol—Fatigue—Ifosfamide—testicular cancer	0.00135	0.00274	CcSEcCtD
Nadolol—Oedema—Cisplatin—testicular cancer	0.00135	0.00273	CcSEcCtD
Nadolol—Constipation—Ifosfamide—testicular cancer	0.00134	0.00271	CcSEcCtD
Nadolol—Pain—Ifosfamide—testicular cancer	0.00134	0.00271	CcSEcCtD
Nadolol—Cardiac failure—Doxorubicin—testicular cancer	0.00134	0.00271	CcSEcCtD
Nadolol—Mood swings—Epirubicin—testicular cancer	0.00134	0.00271	CcSEcCtD
Nadolol—Loss of consciousness—Etoposide—testicular cancer	0.00133	0.0027	CcSEcCtD
Nadolol—Lethargy—Doxorubicin—testicular cancer	0.00133	0.0027	CcSEcCtD
Nadolol—Cough—Etoposide—testicular cancer	0.00132	0.00268	CcSEcCtD
Nadolol—Asthenia—Bleomycin—testicular cancer	0.00131	0.00266	CcSEcCtD
Nadolol—Hypertension—Etoposide—testicular cancer	0.00131	0.00265	CcSEcCtD
Nadolol—Diplopia—Doxorubicin—testicular cancer	0.0013	0.00264	CcSEcCtD
Nadolol—Hyperhidrosis—Cisplatin—testicular cancer	0.0013	0.00264	CcSEcCtD
Nadolol—Pruritus—Bleomycin—testicular cancer	0.0013	0.00263	CcSEcCtD
Nadolol—Dry skin—Epirubicin—testicular cancer	0.00129	0.00262	CcSEcCtD
Nadolol—Chest pain—Etoposide—testicular cancer	0.00129	0.00261	CcSEcCtD
Nadolol—Nausea—Vinblastine—testicular cancer	0.00129	0.00261	CcSEcCtD
Nadolol—Anorexia—Cisplatin—testicular cancer	0.00129	0.00261	CcSEcCtD
Nadolol—Affect lability—Doxorubicin—testicular cancer	0.00128	0.0026	CcSEcCtD
Nadolol—Hypotension—Cisplatin—testicular cancer	0.00126	0.00256	CcSEcCtD
Nadolol—Abdominal discomfort—Methotrexate—testicular cancer	0.00125	0.00253	CcSEcCtD
Nadolol—Gastritis—Epirubicin—testicular cancer	0.00125	0.00253	CcSEcCtD
Nadolol—Body temperature increased—Ifosfamide—testicular cancer	0.00124	0.00251	CcSEcCtD
Nadolol—Mood swings—Doxorubicin—testicular cancer	0.00124	0.0025	CcSEcCtD
Nadolol—Abdominal distension—Epirubicin—testicular cancer	0.00123	0.00249	CcSEcCtD
Nadolol—Asthenia—Dactinomycin—testicular cancer	0.00123	0.00248	CcSEcCtD
Nadolol—Paraesthesia—Cisplatin—testicular cancer	0.00121	0.00246	CcSEcCtD
Nadolol—Dyspnoea—Cisplatin—testicular cancer	0.0012	0.00244	CcSEcCtD
Nadolol—Erectile dysfunction—Methotrexate—testicular cancer	0.0012	0.00243	CcSEcCtD
Nadolol—Dry skin—Doxorubicin—testicular cancer	0.0012	0.00242	CcSEcCtD
Nadolol—Hyperhidrosis—Etoposide—testicular cancer	0.0012	0.00242	CcSEcCtD
Nadolol—Anorexia—Etoposide—testicular cancer	0.00118	0.00239	CcSEcCtD
Nadolol—Decreased appetite—Cisplatin—testicular cancer	0.00117	0.00238	CcSEcCtD
Nadolol—Diarrhoea—Dactinomycin—testicular cancer	0.00117	0.00237	CcSEcCtD
Nadolol—Vomiting—Bleomycin—testicular cancer	0.00116	0.00236	CcSEcCtD
Nadolol—Depression—Methotrexate—testicular cancer	0.00116	0.00235	CcSEcCtD
Nadolol—Hypotension—Etoposide—testicular cancer	0.00116	0.00234	CcSEcCtD
Nadolol—Rash—Bleomycin—testicular cancer	0.00115	0.00234	CcSEcCtD
Nadolol—Gastritis—Doxorubicin—testicular cancer	0.00115	0.00234	CcSEcCtD
Nadolol—Pain—Cisplatin—testicular cancer	0.00115	0.00234	CcSEcCtD
Nadolol—Dermatitis—Bleomycin—testicular cancer	0.00115	0.00234	CcSEcCtD
Nadolol—Abdominal distension—Doxorubicin—testicular cancer	0.00114	0.0023	CcSEcCtD
Nadolol—Conjunctivitis—Methotrexate—testicular cancer	0.00113	0.00229	CcSEcCtD
Nadolol—Asthenia—Ifosfamide—testicular cancer	0.00112	0.00228	CcSEcCtD
Nadolol—Sweating—Methotrexate—testicular cancer	0.00111	0.00226	CcSEcCtD
Nadolol—Paraesthesia—Etoposide—testicular cancer	0.00111	0.00225	CcSEcCtD
Nadolol—Weight increased—Epirubicin—testicular cancer	0.00111	0.00225	CcSEcCtD
Nadolol—Pruritus—Ifosfamide—testicular cancer	0.00111	0.00224	CcSEcCtD
Nadolol—Dyspnoea—Etoposide—testicular cancer	0.0011	0.00223	CcSEcCtD
Nadolol—Nausea—Bleomycin—testicular cancer	0.00109	0.0022	CcSEcCtD
Nadolol—Vomiting—Dactinomycin—testicular cancer	0.00109	0.0022	CcSEcCtD
Nadolol—Agranulocytosis—Methotrexate—testicular cancer	0.00108	0.0022	CcSEcCtD
Nadolol—Rash—Dactinomycin—testicular cancer	0.00108	0.00218	CcSEcCtD
Nadolol—Decreased appetite—Etoposide—testicular cancer	0.00107	0.00218	CcSEcCtD
Nadolol—Diarrhoea—Ifosfamide—testicular cancer	0.00107	0.00217	CcSEcCtD
Nadolol—Body temperature increased—Cisplatin—testicular cancer	0.00107	0.00216	CcSEcCtD
Nadolol—Fatigue—Etoposide—testicular cancer	0.00107	0.00216	CcSEcCtD
Nadolol—Constipation—Etoposide—testicular cancer	0.00106	0.00214	CcSEcCtD
Nadolol—Pain—Etoposide—testicular cancer	0.00106	0.00214	CcSEcCtD
Nadolol—Conjunctivitis—Epirubicin—testicular cancer	0.00106	0.00214	CcSEcCtD
Nadolol—Sweating—Epirubicin—testicular cancer	0.00104	0.00211	CcSEcCtD
Nadolol—Dizziness—Ifosfamide—testicular cancer	0.00104	0.0021	CcSEcCtD
Nadolol—Weight increased—Doxorubicin—testicular cancer	0.00103	0.00208	CcSEcCtD
Nadolol—Nausea—Dactinomycin—testicular cancer	0.00101	0.00206	CcSEcCtD
Nadolol—Agranulocytosis—Epirubicin—testicular cancer	0.00101	0.00206	CcSEcCtD
Nadolol—Visual impairment—Methotrexate—testicular cancer	0.001	0.00204	CcSEcCtD
Nadolol—Vomiting—Ifosfamide—testicular cancer	0.000995	0.00202	CcSEcCtD
Nadolol—Bradycardia—Epirubicin—testicular cancer	0.000993	0.00201	CcSEcCtD
Nadolol—Rash—Ifosfamide—testicular cancer	0.000987	0.002	CcSEcCtD
Nadolol—Dermatitis—Ifosfamide—testicular cancer	0.000986	0.002	CcSEcCtD
Nadolol—Body temperature increased—Etoposide—testicular cancer	0.000977	0.00198	CcSEcCtD
Nadolol—Conjunctivitis—Doxorubicin—testicular cancer	0.000977	0.00198	CcSEcCtD
Nadolol—Tinnitus—Methotrexate—testicular cancer	0.000972	0.00197	CcSEcCtD
Nadolol—Asthenia—Cisplatin—testicular cancer	0.000968	0.00196	CcSEcCtD
Nadolol—Sweating—Doxorubicin—testicular cancer	0.000964	0.00195	CcSEcCtD
Nadolol—Visual impairment—Epirubicin—testicular cancer	0.00094	0.00191	CcSEcCtD
Nadolol—Agranulocytosis—Doxorubicin—testicular cancer	0.000938	0.0019	CcSEcCtD
Nadolol—Nausea—Ifosfamide—testicular cancer	0.00093	0.00188	CcSEcCtD
Nadolol—Diarrhoea—Cisplatin—testicular cancer	0.000923	0.00187	CcSEcCtD
Nadolol—Alopecia—Methotrexate—testicular cancer	0.000921	0.00187	CcSEcCtD
Nadolol—Bradycardia—Doxorubicin—testicular cancer	0.000919	0.00186	CcSEcCtD
Nadolol—Tinnitus—Epirubicin—testicular cancer	0.00091	0.00184	CcSEcCtD
Nadolol—Asthenia—Etoposide—testicular cancer	0.000887	0.0018	CcSEcCtD
Nadolol—Pruritus—Etoposide—testicular cancer	0.000875	0.00177	CcSEcCtD
Nadolol—Visual impairment—Doxorubicin—testicular cancer	0.00087	0.00176	CcSEcCtD
Nadolol—Alopecia—Epirubicin—testicular cancer	0.000862	0.00175	CcSEcCtD
Nadolol—Vomiting—Cisplatin—testicular cancer	0.000858	0.00174	CcSEcCtD
Nadolol—Vision blurred—Methotrexate—testicular cancer	0.000855	0.00173	CcSEcCtD
Nadolol—Rash—Cisplatin—testicular cancer	0.000851	0.00172	CcSEcCtD
Nadolol—Dermatitis—Cisplatin—testicular cancer	0.00085	0.00172	CcSEcCtD
Nadolol—Diarrhoea—Etoposide—testicular cancer	0.000846	0.00171	CcSEcCtD
Nadolol—Tinnitus—Doxorubicin—testicular cancer	0.000842	0.00171	CcSEcCtD
Nadolol—Flatulence—Epirubicin—testicular cancer	0.000837	0.0017	CcSEcCtD
Nadolol—Dizziness—Etoposide—testicular cancer	0.000818	0.00166	CcSEcCtD
Nadolol—Nausea—Cisplatin—testicular cancer	0.000802	0.00162	CcSEcCtD
Nadolol—Vision blurred—Epirubicin—testicular cancer	0.0008	0.00162	CcSEcCtD
Nadolol—Alopecia—Doxorubicin—testicular cancer	0.000798	0.00162	CcSEcCtD
Nadolol—Cough—Methotrexate—testicular cancer	0.000792	0.0016	CcSEcCtD
Nadolol—Vomiting—Etoposide—testicular cancer	0.000786	0.00159	CcSEcCtD
Nadolol—Rash—Etoposide—testicular cancer	0.00078	0.00158	CcSEcCtD
Nadolol—Dermatitis—Etoposide—testicular cancer	0.000779	0.00158	CcSEcCtD
Nadolol—Flatulence—Doxorubicin—testicular cancer	0.000774	0.00157	CcSEcCtD
Nadolol—Chest pain—Methotrexate—testicular cancer	0.000773	0.00157	CcSEcCtD
Nadolol—Syncope—Epirubicin—testicular cancer	0.000762	0.00154	CcSEcCtD
Nadolol—Loss of consciousness—Epirubicin—testicular cancer	0.000746	0.00151	CcSEcCtD
Nadolol—Cough—Epirubicin—testicular cancer	0.000741	0.0015	CcSEcCtD
Nadolol—Vision blurred—Doxorubicin—testicular cancer	0.000741	0.0015	CcSEcCtD
Nadolol—Nausea—Etoposide—testicular cancer	0.000734	0.00149	CcSEcCtD
Nadolol—Hypertension—Epirubicin—testicular cancer	0.000733	0.00149	CcSEcCtD
Nadolol—Chest pain—Epirubicin—testicular cancer	0.000723	0.00147	CcSEcCtD
Nadolol—Hyperhidrosis—Methotrexate—testicular cancer	0.000716	0.00145	CcSEcCtD
Nadolol—Dry mouth—Epirubicin—testicular cancer	0.000707	0.00143	CcSEcCtD
Nadolol—Anorexia—Methotrexate—testicular cancer	0.000706	0.00143	CcSEcCtD
Nadolol—Syncope—Doxorubicin—testicular cancer	0.000705	0.00143	CcSEcCtD
Nadolol—Oedema—Epirubicin—testicular cancer	0.000693	0.0014	CcSEcCtD
Nadolol—Hypotension—Methotrexate—testicular cancer	0.000692	0.0014	CcSEcCtD
Nadolol—Loss of consciousness—Doxorubicin—testicular cancer	0.000691	0.0014	CcSEcCtD
Nadolol—Cough—Doxorubicin—testicular cancer	0.000686	0.00139	CcSEcCtD
Nadolol—Shock—Epirubicin—testicular cancer	0.000682	0.00138	CcSEcCtD
Nadolol—Hypertension—Doxorubicin—testicular cancer	0.000678	0.00137	CcSEcCtD
Nadolol—Hyperhidrosis—Epirubicin—testicular cancer	0.00067	0.00136	CcSEcCtD
Nadolol—Insomnia—Methotrexate—testicular cancer	0.00067	0.00136	CcSEcCtD
Nadolol—Chest pain—Doxorubicin—testicular cancer	0.000669	0.00136	CcSEcCtD
Nadolol—Paraesthesia—Methotrexate—testicular cancer	0.000665	0.00135	CcSEcCtD
Nadolol—Anorexia—Epirubicin—testicular cancer	0.000661	0.00134	CcSEcCtD
Nadolol—Dyspnoea—Methotrexate—testicular cancer	0.00066	0.00134	CcSEcCtD
Nadolol—Dry mouth—Doxorubicin—testicular cancer	0.000654	0.00133	CcSEcCtD
Nadolol—Dyspepsia—Methotrexate—testicular cancer	0.000652	0.00132	CcSEcCtD
Nadolol—Hypotension—Epirubicin—testicular cancer	0.000648	0.00131	CcSEcCtD
Nadolol—Decreased appetite—Methotrexate—testicular cancer	0.000644	0.0013	CcSEcCtD
Nadolol—Oedema—Doxorubicin—testicular cancer	0.000641	0.0013	CcSEcCtD
Nadolol—Fatigue—Methotrexate—testicular cancer	0.000639	0.00129	CcSEcCtD
Nadolol—Pain—Methotrexate—testicular cancer	0.000633	0.00128	CcSEcCtD
Nadolol—Shock—Doxorubicin—testicular cancer	0.000631	0.00128	CcSEcCtD
Nadolol—Insomnia—Epirubicin—testicular cancer	0.000627	0.00127	CcSEcCtD
Nadolol—Paraesthesia—Epirubicin—testicular cancer	0.000622	0.00126	CcSEcCtD
Nadolol—Hyperhidrosis—Doxorubicin—testicular cancer	0.00062	0.00126	CcSEcCtD
Nadolol—Dyspnoea—Epirubicin—testicular cancer	0.000618	0.00125	CcSEcCtD
Nadolol—Anorexia—Doxorubicin—testicular cancer	0.000611	0.00124	CcSEcCtD
Nadolol—Dyspepsia—Epirubicin—testicular cancer	0.00061	0.00124	CcSEcCtD
Nadolol—Decreased appetite—Epirubicin—testicular cancer	0.000603	0.00122	CcSEcCtD
Nadolol—Hypotension—Doxorubicin—testicular cancer	0.000599	0.00121	CcSEcCtD
Nadolol—Fatigue—Epirubicin—testicular cancer	0.000598	0.00121	CcSEcCtD
Nadolol—Constipation—Epirubicin—testicular cancer	0.000593	0.0012	CcSEcCtD
Nadolol—Pain—Epirubicin—testicular cancer	0.000593	0.0012	CcSEcCtD
Nadolol—Body temperature increased—Methotrexate—testicular cancer	0.000585	0.00119	CcSEcCtD
Nadolol—Insomnia—Doxorubicin—testicular cancer	0.00058	0.00118	CcSEcCtD
Nadolol—Paraesthesia—Doxorubicin—testicular cancer	0.000576	0.00117	CcSEcCtD
Nadolol—Dyspnoea—Doxorubicin—testicular cancer	0.000572	0.00116	CcSEcCtD
Nadolol—Dyspepsia—Doxorubicin—testicular cancer	0.000565	0.00114	CcSEcCtD
Nadolol—Decreased appetite—Doxorubicin—testicular cancer	0.000557	0.00113	CcSEcCtD
Nadolol—Fatigue—Doxorubicin—testicular cancer	0.000553	0.00112	CcSEcCtD
Nadolol—Pain—Doxorubicin—testicular cancer	0.000548	0.00111	CcSEcCtD
Nadolol—Constipation—Doxorubicin—testicular cancer	0.000548	0.00111	CcSEcCtD
Nadolol—Body temperature increased—Epirubicin—testicular cancer	0.000548	0.00111	CcSEcCtD
Nadolol—Asthenia—Methotrexate—testicular cancer	0.000531	0.00108	CcSEcCtD
Nadolol—Pruritus—Methotrexate—testicular cancer	0.000524	0.00106	CcSEcCtD
Nadolol—Body temperature increased—Doxorubicin—testicular cancer	0.000507	0.00103	CcSEcCtD
Nadolol—Diarrhoea—Methotrexate—testicular cancer	0.000507	0.00103	CcSEcCtD
Nadolol—Asthenia—Epirubicin—testicular cancer	0.000497	0.00101	CcSEcCtD
Nadolol—Pruritus—Epirubicin—testicular cancer	0.00049	0.000994	CcSEcCtD
Nadolol—Dizziness—Methotrexate—testicular cancer	0.00049	0.000992	CcSEcCtD
Nadolol—Diarrhoea—Epirubicin—testicular cancer	0.000474	0.000961	CcSEcCtD
Nadolol—Vomiting—Methotrexate—testicular cancer	0.000471	0.000954	CcSEcCtD
Nadolol—Rash—Methotrexate—testicular cancer	0.000467	0.000946	CcSEcCtD
Nadolol—Dermatitis—Methotrexate—testicular cancer	0.000467	0.000945	CcSEcCtD
Nadolol—Asthenia—Doxorubicin—testicular cancer	0.00046	0.000932	CcSEcCtD
Nadolol—Dizziness—Epirubicin—testicular cancer	0.000458	0.000929	CcSEcCtD
Nadolol—Pruritus—Doxorubicin—testicular cancer	0.000454	0.000919	CcSEcCtD
Nadolol—Vomiting—Epirubicin—testicular cancer	0.000441	0.000893	CcSEcCtD
Nadolol—Nausea—Methotrexate—testicular cancer	0.00044	0.000891	CcSEcCtD
Nadolol—Diarrhoea—Doxorubicin—testicular cancer	0.000439	0.000889	CcSEcCtD
Nadolol—Rash—Epirubicin—testicular cancer	0.000437	0.000886	CcSEcCtD
Nadolol—Dermatitis—Epirubicin—testicular cancer	0.000437	0.000885	CcSEcCtD
Nadolol—Dizziness—Doxorubicin—testicular cancer	0.000424	0.000859	CcSEcCtD
Nadolol—Nausea—Epirubicin—testicular cancer	0.000412	0.000834	CcSEcCtD
Nadolol—Vomiting—Doxorubicin—testicular cancer	0.000408	0.000826	CcSEcCtD
Nadolol—Rash—Doxorubicin—testicular cancer	0.000404	0.000819	CcSEcCtD
Nadolol—Dermatitis—Doxorubicin—testicular cancer	0.000404	0.000819	CcSEcCtD
Nadolol—Nausea—Doxorubicin—testicular cancer	0.000381	0.000772	CcSEcCtD
